UBU5:F:F-UBS (Irl) ETF Public Limited Company - MSCI USA Value UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 106.92

Change

0.00 (0.00)%

Market Cap

USD 0.78B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-7.46 (-1.28%)

USD 111.88B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.20 (-0.39%)

USD 106.38B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.87 (-1.51%)

USD 105.77B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.05 (-0.35%)

USD 62.83B
VUSA:F Vanguard Funds Public Limited ..

-1.32 (-1.27%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-6.25 (-2.60%)

USD 51.55B
XJSE:F Xtrackers II - Japan Governmen..

-0.22 (-2.84%)

USD 43.00B
0ZC:F Zscaler Inc

+7.08 (+4.05%)

USD 37.92B
BSND:F Danone SA

+0.40 (+2.94%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing UBU5:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.04% 49% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.04% 48% F 51% F
Trailing 12 Months  
Capital Gain 12.50% 66% D+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.50% 63% D 55% F
Trailing 5 Years  
Capital Gain 66.33% 68% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 66.33% 68% D+ 51% F
Average Annual (5 Year Horizon)  
Capital Gain 13.37% 78% C+ 70% C-
Dividend Return 13.37% 76% C+ 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.30% 52% F 84% B
Risk Adjusted Return 100.54% 90% A- 93% A
Market Capitalization 0.78B 69% C- 53% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike